CAS No. |
2242428-57-3 |
|---|---|
中文名称 |
埃卢那韦 |
英文名称 |
Elunonavir |
别名 |
2,5,6,10,13-Pentaazatetradecanedioic acid, 6-[[4-[1-(difluoromethyl)-1H-pyrazol-3-yl]-2,6-difluorophenyl]methyl]-8-hydroxy-9-[[4-[2-[2-[8-(3-oxetanyl)-3,8-diazabicyclo[3.2.1]oct-3-yl]-5-pyrimidinyl]ethynyl]phenyl]methyl]-4,11-dioxo-3,12-bis(2,2,2-trifluoro-1,1-dimethylethyl)-, 1,14-dimethyl ester, (3S,8S,9S,12S)-;2,5,6,10,13-Pentaazatetradecanedioic acid, 6-[[4-[1-(difluoromethyl)-1H-pyrazol-3-yl]-2,6-difluorophenyl]methyl]-8-hydroxy-9-[[4-[2-[2-[8-(3-oxetanyl)-3,8-diazabicyclo[3.2.1]oct-3-yl]-5-pyrimidinyl]ethynyl]phenyl]methyl]-4,11-dioxo-3,12-bis(2,2,2-trifluoro-1,1-dimethylethyl)-, 1,14-dimethyl ester, (...;Elunonavir;GS-1156(Elunonavir);GS-1156;GS-PI1 |
标准英文名 |
methyl ((5S,8S,9S,14S)-11-(4-(1-(difluoromethyl)-1H-pyrazol-3-yl)-2,6-difluorobenzyl)-16,16,16-trifluoro-9-hydroxy-15,15-dimethyl-8-(4-((2-(8-(oxetan-3-yl)-3,8-diazabicyclo[3.2.1]octan-3-yl)pyrimidin-5-yl)ethynyl)benzyl)-3,6,13-trioxo-5-(1,1,1-trifluoro-2-methylpropan-2-yl)-2-oxa-4,7,11,12-tetraazahexadecan-14-yl)carbamate |
分子式 |
C52H59F10N11O8 |
分子量 |
1156.09 |
精确分子量 |
1155.44 |
SMILES |
COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=C(C#CC2=CN=C(N3CC4CCC(C3)N4C3COC3)N=C2)C=C1)[C@@H](O)CN(CC1=C(F)C=C(C2=NN(C(F)F)C=C2)C=C1F)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C(F)(F)F)C(C)(C)C(F)(F)F |
标准SMILES |
COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=C(C=C1)C#CC1=CN=C(N=C1)N1CC2CCC(C1)N2C1COC1)[C@@H](O)CN(CC1=C(F)C=C(C=C1F)C1C=CN(N=1)C(F)F)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C(F)(F)F)C(C)(C)C(F)(F)F |
用途 |
Elunonavir (GS-1156) is an HIV protease inhibitor with a high resistance barrier and excellent metabolic stability; it overcomes rapid CYP-mediated metabolism, significantly prolonging its half-life and potentially reducing dosing frequency without the need for pharmacokinetic boosters. |
InChIKey |
ZTSLYWLHCOINNI-FTEFBJIISA-N |
|
|
评论 |
|---|